H epatocyte growth factor (HGF) is a mesenchymal cell-derived protein mitogenic for primary hepatocytes as well as other cell types. 1,2 HGF also is recognized widely as a multifunctional cytokine and exerts biologic effects through the activation of its specific cell surface receptor, the c-Met proto-oncogene product. 3, 4 Recently, diverse roles of HGF in controlling tumor cell growth have been described: on one hand, HGF is an important growth stimulator for several cell types; on the other hand, the growth of certain tumor cell lines is inhibited by HGF. [5] [6] [7] [8] [9] One notable example of growth inhibition by HGF both in vitro and in vivo is hepatocellular carcinoma (HCC). [7] [8] [9] [10] [11] Although the cyclin-dependent kinase (Cdk) inhibitors such as p21 and p27 are thought to be involved in this process, 12 ,13 the precise molecular mechanisms underlying this growth inhibition by HGF are unknown.
Integrins, particularly ␤1-integrin, are the major components of receptors for the extracellular matrices (ECMs), and they mediate signals from the ECM and regulate a number of cellular activities. 14, 15 We and others have described changes in integrin expression in HCC, indicating overexpression of ␤1-integrin and its potential role in the progression of HCC. [16] [17] [18] [19] ␤1-integrin signaling was shown to protect tumor cells from chemotherapyinduced apoptosis, implicating ␤1-integrin as a survival factor in tumor cells including HCC. [20] [21] [22] [23] Recent observations have shown that both ECM and growth factors work cooperatively through their specific receptors, indicating that interactions between growth factors and ␤1-integrin play important roles in regulating cellular behavior by modulating signaling events. [24] [25] [26] [27] [28] An interaction between the ECM and growth factors also was suggested by showing an association of HGF with the ECM, suggesting that the ECM might regulate the response of cells to HGF. 29, 30 Indeed, HGF/c-Met and ECM components are reported to be present in liver tissue including HCC. [30] [31] [32] However, the role of ␤1-integrin-mediated signals in HCC cells in modulating the response to HGF has not been reported.
In this report, we investigated the effect of ␤1-integrin on the HGF-induced inhibition of HepG2 cell proliferation. We found that ␤1-integrin overexpression restored HGF-induced growth inhibition, and determined that the mechanism responsible for this restoration is via Skp2 and p27 expression.
Materials and Methods
Cells. HepG2 cells overexpressing ␤1-integrin, generated by stable transfection of a human ␤1A-integrin-enhanced green fluorescent protein fusion gene, were described recently by our group. 23 Cells were cultured and maintained in Dulbecco's modified Eagle's medium (GIBCO-BRL, Gaithersburg, MD) containing 10% fetal calf serum (GIBCO-BRL). Cells were treated with recombinant HGF (R&D Systems, Minneapolis, MN) at different concentrations ranging from 0 to 100 ng/mL for 24 or 48 hours.
Plasmids. The full-length human p27 complementary DNA (cDNA) or S-phase kinase-associated protein 2 (Skp2) cDNA was cloned by reverse-transcription polymerase chain reaction (RT-PCR) from parental HepG2 cells. A mammalian expression vector carrying the neo gene as a selectable marker, pcDNA3.1 (ϩ) (Invitrogen, San Diego, CA), was used to clone full-length p27 in the antisense orientation or full-length Skp2 in the sense orientation. Full-length p27 cDNA was synthesized by RT-PCR with the sense primer 5Ј-ggatccATGTCAAACGTGCGCGAGTGTCTAAC-G-3Ј, which introduced a BamHI site, and the antisense primer 5Ј-aagcttACGTTTGACGTCTTCTGAGG-3Ј, which introduced a Hind III site. Full-length Skp2 cDNA was synthesized with the sense primer 5Ј-aagcttATGCA-CAGGAAGCACCTC-3Ј, which introduced a Hind III site, and the antisense primer 5Ј-gtcgacTCATAGA-CAACTGGGCTTTTGCAGTGTCAG-3Ј, which introduced a Sal I site. These RT-PCR products were cloned into the pT7Blue(R)-T vector (Novagen, Madison, WI) to generate pT7p27 or pT7Skp2. The plasmids were sequenced and confirmed to be identical to the reported sequences. The full-length p27 cDNA was subcloned into pcDNAneo3.1 (ϩ) in the antisense orientation to generate pcDNAp27a and the full-length Skp2 cDNA was subcloned in the sense orientation to generate pcDNASkp2.
Stable Transformation of HCC Cells. Plasmids pcDNAp27a, pcDNASkp2, or pcDNA alone as a control were introduced into HepG2 cells using lipofectamine (GIBCO-BRL) according to the manufacturer's instructions. The transfected HCC cells were treated with 500 ng/mL of G418 for 2 weeks and selected. Individual clones of HepG2 cells transduced with antisense p27 or sense Skp2 were analyzed. For the detection of transfected p27 antisense or Skp2 gene expression, RT-PCR with T7 and the sense p27 primers, or with T7 and the antisense Skp2 primers, respectively, were used. Clones showing down-regulation of p27 or overexpression of Skp2 were selected and subjected to further analysis.
Oligonucleotides. The sequences of the oligonucleotide primers used for RT-PCR assays to determine the expression of each human gene are listed, preceded by the GenBank accession number, and followed by the expected transcript sizes: p27 (NM004064): sense 5Ј-TCAAACGTGCGAGTGTCTAA-3Ј, antisense 5Ј-A-CGGATCAGTCTTTGGGTCCA-3Ј, 409 bp; Skp2 (NM005983): sense 5Ј-GAGATTCCAGACCTGAGTA-GC -3Ј, antisense 5Ј-GAGATACCACCTCTTACAAAG-3Ј, 373 bp; glyceraldehyde-3-phosphate dehydrogenase (GAPDH) (NM002046): sense 5Ј-CCACCCATGGCAA-ATTCCATGGCA-3Ј, antisense 5Ј-TCTAGACGGCAG-GTCAGGTCCACC-3Ј, 593 bp.
RNA Extraction and RT-PCR. Total RNA was extracted from cultured HepG2 cells using ISOGEN (Nippon Gene, Tokyo, Japan) according to the manufacturer's instructions. The concentration of RNA was determined spectrophotometrically, and the integrity of all samples was confirmed by visualizing the 28S and 18S ribosomal RNA bands under ultraviolet light after gel electrophoresis. Semiquantitative RT-PCR was performed as reported previously. 19, 33 Briefly, 1 g of total RNA was reverse transcribed with reverse transcriptase using random primers. Subsequently, each RT reaction mixture was subjected to PCR amplification with the number of cycles varying from 15 to 40. Each cycle consisted of a heat denaturation step (94°C for 1 min), an annealing step (55°C for 1 min), and an extension step (72°C for 2 min). The PCR products were size fractionated on a 2% agarose gel, and visualized under ultraviolet light.
Western Blot and Immunoprecipitation Analysis. p27, p21, p18, and Skp2 protein expression was determined by Western analysis. Cultured HepG2 cells were lysed with extraction buffer containing 50 mmol/L Tris (pH 7.5), 150 mmol/L NaCl, 0.1% sodium dodecyl sulfate, 5 mmol/L ethylenediaminetetraacetic acid (pH 8.0), 1 mmol/L phenylmethylsulfonyl fluoride, 10 g/mL trypsin inhibitor, and 50 mmol/L iodoacetamide. After 30 minutes at 4°C, the cellular debris was pelleted by centrifugation at 15,000 rpm for 20 minutes, and the supernatant was collected. After the protein concentration was measured using a protein assay kit (Bio-Rad, Hercules, CA), 40 g of protein were separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis, transferred to a polyvinylidene difluoride membrane (Bio-Rad), and blocked with 0.1% Tween and 5% skim milk overnight. The immunoblots were incubated with anti-p27 mouse monoclonal antibody (Transduction Laboratories, Lexington, NY), anti-p21, p18, and Skp2 rabbit polyclonal antibodies (Santa Cruz Biotechnology, Santa Cruz, CA) in phosphate-buffered saline with 1% bovine serum albumin for 1 hour. Rabbit polyclonal antihuman ␤-actin antibody (Biomedical Technologies, Stoughton, MA) was used as a control. The membrane was washed 3 times with 0.1% Tween 20 in phosphatebuffered saline and stained with a horseradish peroxidaseconjugated secondary antibody. All immunoblots were detected by the enhanced chemiluminescence system (Amersham, Buckinghamshire, England) according to the manufacturer's instructions.
Immunoprecipitations were performed by using Seize X Mammalian Immunoprecipitation Kit (Pierce, Rockford, IL) according to the manufacturer's instructions. Briefly, the anti-GFP antibody (Clontech, Palo Alto, CA) was immobilized onto protein G-agarose using a crosslinking agent, disuccinimidyl substrate. This immobilized anti-GFP antibody was incubated with the cell lysates at 4°C overnight. After washing away the crude material by centrifugation using a Spin X device (porous cup inside of a microcentrifuge tube; Pierce), the remaining antigen was then dissociated from the antibody using an elution buffer and centrifugation. The immunoprecipitates were subjected to sodium dodecyl sulfate-polyacrylamide gel electrophoresis and detected by Western blot analysis using anti-␤1-integrin, ␣1-integrin (Chemicon, Temeculla, CA), ␣5-integrin and ␣6-integrin antibodies (Santa Cruz) as described earlier.
Cell Proliferation Assay. The proliferation of HepG2 cells treated with HGF was determined by measuring the incorporation of 5-bromo-2Ј-deoxyuridine (BrdU) into DNA using a colorimetric BrdU cell proliferation enzyme-linked immunosorbent assay kit (Boehringer Mannheim, Mannheim, Germany) according to the manufacturer's instructions. Cells were seeded in 24-well culture plates at a density of 10 4 cells/well, incubated at 37°C for 24 hours, and incubated with HGF at the indicated concentration for the next 48 hours. Then BrdU labeling solution was added and incubated for 8 hours at 37°C. Thereafter, FixDenat solution (Boehringer Mannheim) was added and incubated for 30 min- utes at room temperature. Finally, anti-BrdU-peroxidase solution was added for 90 minutes at room temperature. At the end of the assay, substrate solution was filled into each well. After 15 minutes of incubation at room temperature, absorbance of the samples was assessed at 370 nm with a reference wave length of 492 nm using a CS-9300PC microplate reader (Shimadzu, Tokyo, Japan).
Statistical Analysis. Differences were determined using Student's t test, and a P value of less than .05 was considered significant. All experiments were performed at least in triplicate. Data are shown as the mean Ϯ SD.
Results
Association of Transfected ␤1-Integrin-GFP Fusion Protein With Integrin ␣ Subunits. HepG2 cells transfected with a full-length ␤1A-integrin fused with GFP (pEGFP-N1/GF␤1A) or pEGFP-N1 vector alone were described recently, and the increased expression of ␤1-integrin in transfected hepatoma cells was shown. 23 To confirm the association of endogenous ␣ integrin subunits with transfected ␤1-integrin-GFP fusion gene products, cell lysates were immunoprecipitated with anti-GFP antibody, then followed by western blotting using anti-GFP, ␤1-integrin, ␣1-integrin, ␣5-integrin, and ␣6-integrin antibodies. Results from parental, mock, and 2 representative clones of HepG2 cells transfected with ␤1-integrin-GFP fusion gene are shown in Fig. 1A . A 27-kd band of GFP was found in mock-transfected cells, and a 140-kd band corresponding to the size of the fusion protein of ␤1-integrin (113 kd) and GFP (27 kd) was detected in ␤1-integrin-transfected cells, whereas no band reactive to GFP was detected in parental HepG2 cells. No band corresponding free GFP was detected in ␤1-integrin-transfected HepG2 cells, indicating that the ␤1-integrin-GFP fusion protein is intact in these transfectants. Importantly, ␤1-integrin, ␣1-integirn, ␣5-integrin, and ␣6-integrin were detected in cells transfected with ␤1-integrin-GFP fusion gene but not in parental and mocktransfected cells, indicating that the endogenous ␣ integrin subunits could dimerize with transfected ␤1-integrin. Moreover, GFP protein expression also was detected by fluorescence microscopy (Fig. 1B) . Although GFP was located diffusely in both nucleus and cytoplasm of mock-transfected HepG2 cells, it was present on cell membrane and in cytoplasm in cells transfected with ␤1-integrin-GFP fusion gene. A dense spot of GFP was observed in the region forming adhesion macula in ␤1-integrin-transfected cells, suggesting that transfected ␤1-integrin was functional.
HGF-Induced Proliferation Inhibition of HepG2 Cells Was Reversed by ␤1-Integrin Overexpression. Parental, mock-transfected, and ␤1-integrin-transfected HepG2 cells were treated with HGF for 48 hours, and the BrdU incorporation during DNA synthesis of these cells was assayed (Fig. 2) . In agreement with previous reports, 8, 9 HGF inhibited the DNA synthesis of the parental and mock-transfected HepG2 cells in a dose-dependent manner. However, up to 100 ng/mL of HGF failed to suppress the proliferation of the HepG2 cells that overexpressed ␤1-integrin; in fact, the proliferation of the ␤1-integrin transfectants was increased after HGF treatment.
Induction of p27 by HGF Was Prevented in HepG2 Cells Overexpressing ␤1-Integrin. To determine whether Cdk inhibitors were involved in the altered response of ␤1-integrin-transfected HepG2 cells to HGF, the expression of several Cdk inhibitors such as p27, p21, and p18 were assayed by Western analysis. As shown in Fig. 3A, p27 protein accumulated in the parental and mock-transfected HepG2 cells. However, HGF did not induce the accumulation of p27 in the ␤1-integrin-transfected HepG2 cells. On the other hand, the levels of p21 and p18 were not changed in the parental, mock, and ␤1-integrin-transfected cells. The expression of p27 messenger RNA (mRNA) also was examined by semiquantitative RT-PCR. As shown in Fig. 3B , HGF increased p27 mRNA in the parental and mock-transfected HepG2 cells, but HGF did not increase p27 mRNA in the ␤1-integrin-transfected HepG2 cells.
HGF Failed to Induce Proliferation Inhibition in Antisense p27-Transfected HepG2 Cells. To investigate the role of p27 in HGF-induced proliferation inhibition, HepG2 cells were stably transfected with antisense p27, and clones that down-regulated p27 expression were selected. Results from the parental, mock-transfected cells, and 2 representative clones of HepG2 cells are shown in Fig. 4A . The p27 transgene detected by RT-PCR with T7 and sense p27 primers were found only in the cells transfected with antisense p27 but not in the parental and mock-transfected cells. The total amount of p27 mRNA was decreased in the antisense p27-transfected HepG2 cells compared with the parental and mock-transfected cells. Western analysis showed significantly less p27 protein in the antisense p27-transfected HepG2 cells than that in the parental and mock-transfected cells (Fig. 4B) . Importantly, compared with the mock-transfected cells, the HepG2 cell clones transfected with antisense p27 did not show increased p27 mRNA or protein after HGF treatment (Fig. 4C) . Furthermore, when these cells were treated with HGF, the proliferation inhibitory effect of HGF was abolished; instead, a proliferation stimulatory effect was observed (Fig. 4D) .
HGF Reduced Skp2 Expression in HepG2 Cells but Not in ␤1-Integrin-Transfected HepG2 Cells. It has been reported recently that Skp2 displays an S-phase promoting function and is involved in the ubiquitin-dependent degradation of p27 protein. 34, 35 Because differential effects of HGF and ␤1-integrin on p27 expression in HepG2 cells were observed, the expression and role of Skp2 in these processes induced by HGF and ␤1-integrin were investigated. First, Skp2 expression was determined by RT-PCR and Western analysis in parental, mocktransfected, and ␤1-integrin-transfected HepG2 cells. As shown in Fig. 5A , compared with the parental and mocktransfected cells, increased Skp2 mRNA and protein were observed in the ␤1-integrin-transfected HepG2 clones. Second, Skp2 expression was examined in these cells after HGF treatment. As shown in Fig. 5B , HGF dose-dependently reduced Skp2 mRNA and protein expression in parental and mock-transfected HepG2 cells. However, HGF did not reduce either the Skp2 mRNA or protein levels in the ␤1-integrin-transfected HepG2 cells.
Skp2 Overexpression Abolishes the Response to HGF in HepG2 Cells. To identify the role of Skp2 in HGF-induced proliferation inhibition in HepG2 cells, cells were stably transfected with full-length Skp2 cDNA and cells overexpressing Skp2 were selected. Results from the parental, mock-transfected cells, and 2 representative clones of HepG2 cells are shown in Fig. 6A . The Skp2 transgene, detected by RT-PCR with T7 and antisense Skp2 primers, was found only in cells transfected with sense Skp2, and not in the parental or mock-transfected cells. The total amount of Skp2 mRNA was increased in the Skp2-transfected HepG2 cells compared with the parental and mock-transfected cells. The level of p27 mRNA was not altered in the cells transfected with Skp2 cDNA. As shown in Fig. 6B , Western analysis showed significantly more Skp2 protein in the Skp2-transfected HepG2 cells than in the parental and mock-transfected cells. Importantly, the Skp2 transfectants contained less p27 protein than did the parental and mock-transfected cells. Next, HepG2 cells were treated with HGF and changes in the expression of Skp2 and p27 were assayed.
As shown in Fig. 5C , treatment of HepG2 cells overexpressing Skp2 with HGF did not change the p27 and Skp2 protein levels, whereas HGF treatment reduced Skp2 expression and resulted in the accumulation of p27 in the parental and mock-transfected HepG2 cells (Figs.  3, 4, and 5) . Furthermore, overexpression of Skp2 attenuated the dose-dependent inhibition of DNA synthesis by HGF to the control level (Fig. 6D ).
Discussion
HGF, first identified as a potent growth stimulator of normal hepatocytes, 1,2 has diverse effects on liver development, regeneration after tissue injury by regulating angiogenesis and ECM metabolism, and on tumorigenesis. [5] [6] [7] [8] [9] [10] [11] [12] [13] [36] [37] [38] In HCC, HGF has been shown to inhibit hepatoma cell growth both in vitro and in vivo. [7] [8] [9] [10] [11] Previous studies investigating the mechanism by which HGF suppresses hepatoma cells, although it has not been elucidated clearly, have implicated the involvement of Cdk inhibitors, a group of negative regulators of the cell cycle. 12,13 Nagahara et al. 13 showed that HGF treatment induced the accumulation of p27 in HepG2 cells, resulting in G1 cell-cycle arrest. Consistent with these observations, our experiments showed that the down-regulation of p27 by antisense p27 abrogated the HGF-induced suppression of HepG2 cell growth, suggesting a critical role of p27 in HepG2 proliferation. However, the details of the mechanism by which HGF induces p27 expression remain to be elucidated. Recently, Skp2, a member of the F-box family, which possesses substrate-recognition subunits in the Skp1-Cul1-F-box (SCF) ubiquitin-protein ligase complexes and an S-phase promoting function, has been shown to be involved in the ubiquitination-mediated degradation of several regulators of cell cycle progression including p27 both in vitro and in vivo. 34, 35 Therefore, the observation that Skp2 can promote the ubiquitin-mediated proteolysis of p27 prompted us to examine the role of Skp2 in HGF-induced induction in HepG2 cells. The results presented here revealed a previously unknown biologic action of HGF that decreases both the mRNA and protein levels of Skp2 in HepG2 cells, suggesting that the increase in p27 protein is caused, at least in part, by the HGF-induced suppression of Skp2. These results are consistent with a recent report that showed that the targeted disruption of Skp2 leads to an accumulation of p27 and cell cycle arrest in G1. 39 Collectively, our data suggest the presence of 2 pathways in HGF-induced p27 accumulation, one that is caused by the activation of p27 gene expression, and the other that is caused by the inhibition of p27 degradation by downregulating Skp2 expression, resulting in the growth inhibition of HepG2 cells by HGF.
We showed that overexpression of ␤1-integrin converted the response of HepG2 cells to HGF from growth suppression to growth stimulation, suggesting that ␤1-integrin can modulate the effects of HGF in HepG2 cells. ␤1-integrin is a major component of the ECM receptor and transmits signals from the outside environment and plays important roles in growth, differentiation, and tumorigenesis. 14, 15 Previous observations showed that there are cross-talks among the signals mediated by various growth factors such as HGF, epidermal growth factor, platelet-derived growth factor, or transforming growth factor ␤1, and integrins, and that they cooperatively transmitted signals and exerted their effects. [24] [25] [26] [27] [28] Our data suggest that ␤1-integrin prevents HGF-induced growth inhibition in HepG2 cells by up-regulating Skp2 expression, which promotes the degradation of p27 protein. Furthermore, this conclusion was confirmed in Skp2 overexpressed HepG2 cells, which had less p27 protein and did not show HGF-induced growth suppression. Interestingly, Skp2 overexpression did not rescue the HGFinduced growth suppression in HepG2 cells to the same extent as that induced by ␤1-integrin or antisense p27, although it did reverse them to the same growth level of the untreated parental HepG2 cells. This observation suggests the presence of one or more additional pathway(s) to control HGF-induced cell cycle progression through p27 in addition to a Skp2-dependent pathway. It has been reported that increased expression of Skp2 is observed frequently in various cancers and correlated with a poor prognosis, suggesting that Skp2 may contribute to the growth and expansion of tumor cells. 40, 41 Recently, Carrano and Pagano 42 reported that Skp2 is a target of ECM signaling in controlling cell proliferation, and the induction of Skp2 is dependent on cell adhesion to ECM. Consistent with this observation, our results showed that Skp2 is a downstream target of ␤1-integrin, and therefore an increased level of Skp2 mediated by ␤1-integrin might be linked to the acquisition of the malignant phenotype of hepatoma cells by allowing them to escape from the growth-suppressive effects of HGF. These effects mediated by ␤1-integrin from the ECM also might contribute to disease progression of HCC.
The interactive pathways between HGF and ␤1-integrin in our study are shown in Fig. 7 . Besides the ␤1-integrin-mediated interactive pathway shown here, several molecules were shown to interact with HGF/cMet signaling. HGF receptor c-Met has been shown to bind directly to the death receptor Fas and prevent Fasinduced apoptosis by sequestering Fas from Fas ligand binding. 43 Price et al. 44 showed that insulin-like growth factor I rescued HGF-induced growth inhibition in hepatoma cells by a mitogen-activated protein (MAP) kinasedependent pathway. Interestingly, the activity level of ERK-MAP kinase was shown to be associated closely with proliferation of HepG2 cells regulated by HGF. 45 Involvement of c-Jun N-terminal kinase pathway in association with ERK-MAP kinase pathway was shown in HGF-induced apoptosis of liver epithelial cells. 46 Because ␤1-integrin signaling is connected to MAP kinase pathway and contributes to regulate cell cycle progression, 47, 48 it is possible that MAP kinase pathway is involved in ␤1-integrin-mediated modulation of hepatoma cell growth regulated by HGF in addition to interaction between Skp2 and p27. Further analysis of the precise role of MAP kinase pathway in ␤1-integrin-mediated modulation of hepatoma cell growth is required.
In conclusion, HGF inhibited cell cycle progression in hepatoma cells by increasing the expression of the Cdk inhibitor p27, in part via a down-regulation of Skp2 expression. Furthermore, ␤1-integrin overexpression converted the phenotype of HepG2 cells induced by HGF from that of inhibition to growth stimulation. The presence of an interaction between the HGF-mediated signal and the ␤1-integrin signal mediated by ECM could modulate the growth of hepatoma cells, thus contributing to disease progression. Accordingly, these pathways could be therapeutic targets in patients with HCC.
